PharVision Advisers’s Datadog DDOG Stock Holding History

PharVision Advisers’s Portfolio DDOG Stock Details DDOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,930	Closed	-$275K	–	754
2025 Q3	$275K	Buy	+1,930	New	+$266K	0.15%	278

Other funds holding DDOG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's DDOG Position: Q4 2025 in Review

PharVision Advisers sold out of Datadog (DDOG) in Q4 2025, closing a stake of 1,930 shares — an estimated $275K sold.

PharVision Advisers first reported a position in DDOG in Q3 2025 and held it in 1 quarter. The position peaked at $275K in Q3 2025. 1,057 funds tracked by Wall St. Rank hold DDOG as of Q4 2025.

PharVision Advisers reported no remaining Datadog position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,930 Datadog shares in Q4 2025, an estimated $275K.
PharVision Advisers first reported a position in Datadog in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Datadog position peaked at $275K in Q3 2025.
1,057 funds tracked by Wall St. Rank held Datadog as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.